Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The PENTO Protocol in Medication-related Osteonecrosis of the Jaw
NCT05795647Phase 2Recruiting
- Sponsor
- CHU de Limoges
- Start
- Feb 2024
- Primary completion
- Apr 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline, tocopherol in medication-related osteonecrosis of the jaw (MRONJ), sponsored by CHU de Limoges. Started Feb 2024; status: recruiting.
02
Drugs
pentoxifyllinetocopherol
03
Conditions
medication-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on NCT05795647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05795647.